Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Alembic Limited (ALEMBICLTD) Stock Price & Analysis

3 Followers

ALEMBICLTD Stock Chart & Stats

₹115.67₹9.65(9.10%)
At close: 3:30 PM GMT+5:30
₹90₹100₹110Aug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 105.56 - INR 116.90
52-Week Range
INR 70.64 - INR 117.91
Previous Close
INR 106.02
Volume
N/A
Average Volume (3M)
75.71K
Market Cap
INR 27.22B
Enterprise Value
INR 17.32B
Total Cash (Recent Filing)
INR 980.38M
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
8.4
Beta
1.48
Next Earnings
Feb 17, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Aug 04, 2026
Dividend Yield
2.08%

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

Alembic’s minimal debt burden reduces solvency and refinancing risk while preserving financial flexibility. A conservatively financed balance sheet can support investment, dividends, or resilience during weaker operating periods without the pressure of substantial interest obligations.

Steady Revenue Growth

The multi-year increase in revenue indicates sustained expansion rather than reliance on a single reporting period. Continued top-line growth across pharmaceutical products and markets can broaden the earnings base and provide operating scale for future performance.

Improving Cash Generation

The sharp improvement in operating and free cash flow strengthens the company’s ability to fund operations internally and support capital allocation. If maintained, better cash conversion would complement the low-debt balance sheet and improve financial resilience.

Bears Say

Operating Profitability Weakened

The decline in EBITDA and EBIT shows that operating performance weakened despite continued revenue growth. If this deterioration persists, it could reduce the company’s ability to translate its expanding sales base into durable operating earnings and limit internally funded growth.

Volatile Cash Conversion

Historically uneven operating and free cash flow indicates that reported performance has not consistently translated into cash. Such volatility can complicate investment planning and capital allocation, even though cash generation improved materially in the latest period.

Earnings Quality Concern

Net income exceeding revenue raises uncertainty about how much reported profitability comes from recurring pharmaceutical operations versus other or potentially non-recurring items. This makes sustainable earnings power harder to assess and increases the importance of operating-profit trends.

Alembic Limited News

ALEMBICLTD FAQ

What was Alembic Limited’s price range in the past 12 months?
Alembic Limited lowest stock price was ₹70.64 and its highest was ₹117.91 in the past 12 months.
What is Alembic Limited’s market cap?
Alembic Limited’s market cap is ₹27.22B.
When is Alembic Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alembic Limited’s earnings last quarter?
Alembic Limited released its earnings results on Aug 11, 2026. The company reported ₹2.527 earnings per share for the quarter.
Is Alembic Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Alembic Limited pay dividends?
Alembic Limited pays an annual dividend of ₹2.4 which represents an annual dividend yield of 2.08%. See more information on Alembic Limited dividends here
What is Alembic Limited’s EPS estimate?
Alembic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alembic Limited have?
Alembic Limited has 256,781,830 shares outstanding.
What happened to Alembic Limited’s price movement after its last earnings report?
Alembic Limited reported an EPS of ₹2.527 in its last earnings report. Following the earnings report the stock price went up 3.694%.
Which hedge fund is a major shareholder of Alembic Limited?
Currently, no hedge funds are holding shares in IN:ALEMBICLTD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology